Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-03-27, Stock:JNJ, The news for the past five days is as follows:
2019-03-20: NEWS1: FedEx, Johnson and Johnson slump while General Mills rises.NEWS2: Bayer Stock Tumbles After Jury Finds Weed-Killer Roundup Caused Cancer.NEWS3: AbbVie's Venclexta Multiple Myeloma Studies Put on Hold by FDA.NEWS4: AbbVie's Venclexta Multiple Myeloma Studies Put on Hold by FDA.NEWS5: US STOCKS-FedEx outlook weighs on Wall St ahead of Fed policy decision.NEWS6: AbbVie's Venclexta Multiple Myeloma Studies Put on Hold by FDA.NEWS7: US STOCKS-Wall St drops after weak FedEx outlook; Fed on tap.NEWS8: Health Care Sector Update for 03/20/2019: MTFB, NVRO, ZEAL, ALXN, JNJ, PFE, ABT, MRK, AMGN.NEWS9: Health Care Sector Update for 03/20/2019: MTFB, NVRO, ZEAL, ALXN, JNJ, PFE, ABT, MRK, AMGN.NEWS10: Stocks making the biggest moves premarket: General Mills, Johnson & Johnson, Viacom, Sony & more.NEWS11: Stocks making the biggest moves premarket: General Mills, Johnson & Johnson, Viacom, Sony & more.NEWS12: 3 Dividend Stocks Ideal for Retirees.NEWS13: 3 Dividend Stocks Ideal for Retirees.NEWS14: 3 Dividend Stocks Ideal for Retirees.
2019-03-21: NEWS1: J&J to record $700 million charge related to abandoned drug program.NEWS2: J&J to record $700 mln charge related to abandoned drug program.NEWS3: Cramer: Investors need a new playbook now that the Fed ended rate hikes this year.NEWS4: Here’s What the Apple Watch Means for AAPL Stock.NEWS5: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS6: Biogen’s Big Bet in Alzheimer’s Disease Is a Bust.NEWS7: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS8: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS9: Cooper Companies' (COO) CooperVision Gains Momentum Globally.NEWS10: Cooper Companies' (COO) CooperVision Gains Momentum Globally.NEWS11: Cooper Companies' (COO) CooperVision Gains Momentum Globally.NEWS12: Dear Apple, Is My Heart OK?.NEWS13: Dear Apple, Is My Heart OK?.NEWS14: Alkermes Focuses on Pipeline, Depends on Partners for Funds.NEWS15: Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN.NEWS16: Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN.NEWS17: Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019.NEWS18: Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 22, 2019.NEWS19: Dear Apple, Is My Heart OK?.NEWS20: Microsoft Stock Is Just Too Good to Buy Right Now.
2019-03-22: NEWS1: 11 Dividend Stocks With 55 or More Years of Payout Growth.NEWS2: 11 Dividend Stocks With 55 or More Years of Payout Growth.NEWS3: Confessions of a beauty insider: The best and worst products for your skin.NEWS4: 11 Dividend Stocks With 55 or More Years of Payout Growth.NEWS5: Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook.NEWS6: Here’s What the Apple Watch Means for AAPL Stock.NEWS7: Here’s What the Apple Watch Means for AAPL Stock.
2019-03-25: NEWS1: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS2: Oklahoma top court clears way for Purdue, J&J, Teva to face opioid trial.NEWS3: Johnson & Johnson (JNJ): Are Hedge Funds Right About This Stock?.NEWS4: Markets Right Now: Stock indexes end an indecisive day mixed.NEWS5: Raymond James Expects Johnson & Johnson's Growth To Accelerate Into 2020.NEWS6: Johnson & Johnson and Bayer settle Xarelto lawsuits for $775 million.NEWS7: European shares slip for fourth day on growth, Brexit concerns.NEWS8: US experts revisit breast implant safety after new concerns.NEWS9: J&J Files Application for Darzalex Label Expansion in Europe.NEWS10: J&J Files Application for Darzalex Label Expansion in Europe.NEWS11: Settlement Reached Resolving Xarelto Multidistrict Litigation Claims.NEWS12: Bayer, J&J settle thousands of U.S. Xarelto lawsuits for $775 million.NEWS13: Markets Right Now: US stock indexes turn mixed.NEWS14: Bayer, J&J settle thousands of U.S. Xarelto lawsuits for $775 million.NEWS15: Bayer, J&J settle U.S. Xarelto litigation for $775 million.NEWS16: Bayer, J&J settle thousands of U.S. Xarelto lawsuits for $775 mln.NEWS17: J&J Files Application for Darzalex Label Expansion in Europe.NEWS18: S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion.NEWS19: Health Care Sector Update for 03/25/2019: NK, MDWD, AIMT, JNJ, PFE, ABT, MRK, AMGN.NEWS20: Health Care Sector Update for 03/25/2019: NK, MDWD, AIMT, JNJ, PFE, ABT, MRK, AMGN.NEWS21: Markets Right Now: US stocks open slightly higher.NEWS22: Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook.
2019-03-26: NEWS1: Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million.NEWS2: Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million.NEWS3: Amid talk of buyout, Peninsula biotech zeroes in on its blood-thinner antidote.NEWS4: Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case.NEWS5: Purdue Pharma agrees to $270 mln settlement in Oklahoma opioid case.NEWS6: Bayer & JNJ Settle Numerous Xarelto Lawsuits for $775 Million.NEWS7: 5 Must-See Stock Charts: Oil, JNJ, BBBY, CCL, and NIO.NEWS8: Dow Jones Climbs As One Of Its Maligned Stocks Nears Buy Point.NEWS9: OxyContin Maker Purdue Pharma Agrees to $270 Million Settlement With Oklahoma.NEWS10: Health Care Sector Update for 03/26/2019: ALDX, ZOM, CANF, NNVC, JNJ, PFE, ABT, MRK, AMGN.NEWS11: Health Care Sector Update for 03/26/2019: ALDX, ZOM, CANF, NNVC, JNJ, PFE, ABT, MRK, AMGN.NEWS12: OxyContin maker Purdue agrees to settle Oklahoma opioid case - source.NEWS13: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.NEWS14: Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know.

Answer: Rise